Mamatha Katikaneni, MD
Rheumatology · Shreveport, LANPI 1902110109
Payments from drug & device makers
Across 780 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- Novartis$1K
- Johnson & Johnson$983
- UCB, Inc.$753
- E.r. Squibb & Sons, L.L.C.$623
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 257 | $4,333 |
| AbbVie | 138 | $2,709 |
| Novartis | 62 | $1,117 |
| Johnson & Johnson | 58 | $983 |
| UCB, Inc. | 40 | $753 |
| E.r. Squibb & Sons, L.L.C. | 32 | $623 |
| GSK | 39 | $582 |
| Pfizer | 32 | $475 |
| Genentech USA, Inc. | 27 | $451 |
| Mallinckrodt Hospital Products Inc. | 16 | $388 |
| Lilly USA, LLC | 16 | $290 |
| Boehringer Ingelheim | 9 | $179 |
| Radius Health, Inc. | 7 | $155 |
| Scilex Pharmaceuticals Inc. | 4 | $138 |
| Aurinia Pharma U.S., Inc. | 7 | $137 |
| ANI Pharmaceuticals, Inc. | 6 | $126 |
| AstraZeneca | 8 | $121 |
| Sanofi | 4 | $114 |
| Boston Scientific | 3 | $67 |
| Pacira Therapeutics, Inc. | 2 | $57 |
| Actelion Pharmaceuticals US, Inc. | 3 | $47 |
| Sobi, Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Alvogen Inc | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
| Regeneron | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Organon | 1 | $15 |
How this compares
$14,042 in reported general payments places this provider in the 60th percentile of 88 rheumatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Shreveport
- Aaron BroadwellShreveport$1.7M
- Robert GoodmanShreveport$148K
- Frankie PedigoShreveport$98K
- Samina HayatShreveport$83K
- Sarwat UmerShreveport$68K
- Thomas PresslyShreveport$37K
- Larry BroadwellShreveport$33K
- Richa DhawanShreveport$19K
- Mary WaltonShreveport$16K
- Kyla LokitzShreveport$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.